Case Report
A Catheter-Related Bloodstream Infection by Brevibacterium casei in a Child with Acute Myeloid Leukemia: Case Report and Literature Review
Table 1
Characteristics, treatment, and outcomes of the Brevibacterium casei infection cases identified in a PubMed search conducted in March 2020.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
∗Child. †Intravitreal injection. ‡Duration of the treatment. AIDS, acquired immunodeficiency syndrome; ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; AMPC, amoxicillin; CAZ, ceftazidime; CEZ, cefazolin; CEX, cephalexin; CKH, congenital kidney hypoplasia; CPFX, ciprofloxacin; CRBSI, catheter-related bloodstream infection; CTX, cefotaxime; CVA/AMPC, clavulanate/amoxicillin; CVC, central venous catheter; F, female; FN, febrile neutropenia; HD, hemodialysis; LZD, linezolid; M, male; MEPM, meropenem; MFLX, moxifloxacin; N/A, not available; NHL, non-Hodgkin's lymphoma; PD, peritoneal dialysis; PH, pulmonary hypertension; PIPC, piperacillin; Ref, reference; SLE, systemic lupus erythematosus; TAZ/PIPC, tazobactam/piperacillin; TEIC, teicoplanin; TOB, tobramycin; y, year; VCM, vancomycin. |